{"id":"CHEMBL105060","canonicalSmiles":"CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1","inchiKey":"BHCJHYIMNHXLOM-WVDRJWPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DNK333","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dnk333"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0000341","EFO_0000274"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL105442","canonicalSmiles":"O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl","inchiKey":"GFMMXOIFOQCCGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CI-1040","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-1040","Ci 1040","Ci-1040","PD-18435","PD-184352"],"crossReferences":{"PubChem":["144206914","170466835","174006413"],"drugbank":["DB12429"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003869","EFO_0003860","MONDO_0008903","EFO_0004142","MONDO_0007254","EFO_0003060","EFO_1001951"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1069","canonicalSmiles":"CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C","inchiKey":"ACWBQPMHZXGDFX-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALSARTAN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diovan","Exforge","Prexxartan","Valsartan"],"synonyms":["CGP 48933","CGP-48933","NSC-758927","Valsartan"],"crossReferences":{"DailyMed":["valsartan"],"PubChem":["26719825"],"Wikipedia":["Valsartan"],"drugbank":["DB00177"],"chEBI":["9927"]},"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003086","EFO_0000275","MONDO_0002009","EFO_0000401","EFO_0000373","EFO_1001461","EFO_0000538","EFO_0005952","EFO_1000637","EFO_0007148","Orphanet_63","EFO_0003914","MONDO_0001302","EFO_0008585","Orphanet_93262","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0000400","EFO_0000407","EFO_0008586","EFO_0000694","MONDO_0005149","HP_0002140","HP_0003124","EFO_0005529","EFO_0001645","EFO_0000319","EFO_0004194","Orphanet_309005","EFO_0000537","EFO_0003146","EFO_0000195","HP_0012664","MONDO_0001134","MONDO_0100096","EFO_0008583","EFO_0000612","EFO_1001207","HP_0031273","MONDO_0005148","HP_0012594","EFO_0005672","EFO_0004265"],"count":45},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 8 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL108778","canonicalSmiles":"CC(C)C(=O)O","inchiKey":"KQNPFQTWMSNSAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOBUTYRIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isobutyric Acid"],"crossReferences":{"PubChem":["144208405"],"Wikipedia":["Isobutyric_acid"],"drugbank":["DB02531"],"chEBI":["16135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1088","canonicalSmiles":"CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21","inchiKey":"SLVMESMUVMCQIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MESORIDAZINE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lidanar"],"synonyms":["Mesoridazine","NC-123","NSC-186066","Serentil","TPS-23","Thioridazine-2-sulfoxide"],"crossReferences":{"PubChem":["144203603","144205571","170465272","26756521","447728"],"Wikipedia":["Mesoridazine"],"drugbank":["DB00933"],"chEBI":["6780"]},"childChemblIds":["CHEMBL1201052"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970 and is indicated for psychosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL109367","canonicalSmiles":"CC(C)C1=NCCc2ccc(NC(=O)c3ccc4cc(C(=N)N)ccc4c3)cc21","inchiKey":"XRHANBWAKSYPEN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109367","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02473"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1159662","canonicalSmiles":"O[C@@H]1CO[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"SRBFZHDQGSBBOR-TXICZTDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOSE (PYRANOSE)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Ribose","Ribose","Ribose (pyranose)"],"crossReferences":{"Wikipedia":["Ribose"],"drugbank":["DB04286"],"chEBI":["27476"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL116455","canonicalSmiles":"O=C(O)CS","inchiKey":"CWERGRDVMFNCDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOGLYCOLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mercaptoacetic acid","NSC-1894","Thioglycolic acid","Thioglycollic acid"],"crossReferences":{"PubChem":["144208915","144213623","68624"],"Wikipedia":["Thioglycolic_acid"],"drugbank":["DB15429"],"chEBI":["30065"]},"childChemblIds":["CHEMBL3187776"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200610","canonicalSmiles":"N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1.O","inchiKey":"GPYKKBAAPVOCIW-HSASPSRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORACARBEF","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1013","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lorabid"],"synonyms":["LY-163892 MONOHYDRATE","LY163892 MONOHYDRATE","Loracarbef","Loracarbef monohydrate"],"crossReferences":{"PubChem":["144206680"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1200628","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.Cl","inchiKey":"LCTORFDMHNKUSG-XTTLPDOESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VANCOMYCIN HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL262777","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firvanq kit","Vancocin","Vancocin hydrochloride","Vancocin matrigel","Vancoled","Vancomycin hydrochloride","Vancor","Vanoled"],"synonyms":["Firvanq","NSC-757377","Vancomycin (as hydrochloride)","Vancomycin hcl","Vancomycin hydrochloride","Vancomycin monohydrochloride","Vancomycin, monohydrochloride"],"crossReferences":{"DailyMed":["vancomycin%20hydrochloride"],"PubChem":["50107218"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for infection and endocarditis and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200748","canonicalSmiles":"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O","inchiKey":"QTAOMKOIBXZKND-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBIDOPA","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201236","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbidopa","Lodosyn"],"synonyms":["Carbidopa","Carbidopa anhydrous","Carbidopa hydrate","Carbidopa monohydrate","Carbidopum monohydrate","Lodosyn","MK-486","NSC-751137","NSC-758190"],"crossReferences":{"chEBI":["3395"]},"linkedTargets":{"rows":["ENSG00000132437"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_0005687","EFO_0001365","EFO_1000809","EFO_0005252","EFO_1001919","EFO_0003768","Orphanet_72","Orphanet_1764","MONDO_0002050","MONDO_0005180","EFO_0000712","EFO_1001402","MONDO_0001162","MONDO_0004976","EFO_0003888","HP_0012532","EFO_0004329","MONDO_0001020","EFO_0003770","Orphanet_55","HP_0002381","HP_0003418","EFO_0003843","EFO_0000537","Orphanet_791","EFO_0000546","EFO_1001175","MONDO_0005301","MONDO_0004979"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 4 approved and 21 investigational indications."}
{"id":"CHEMBL1200831","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2.Cl","inchiKey":"CLDOLNORSLLQDI-OOAIBONUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPIRAPRIL HYDROCHLORIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL431","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Renormax"],"synonyms":["SCH 33844","SCH-33844","Spirapril hcl","Spirapril hydrochloride"],"crossReferences":{"PubChem":["144206534"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994."}
{"id":"CHEMBL1200955","canonicalSmiles":"COc1c(C)c2c(c(O)c1C/C=C(\\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2.Cl","inchiKey":"OWLCGJBUTJXNOF-HDNKIUSMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MYCOPHENOLATE MOFETIL HYDROCHLORIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cellcept","Mycophenolate mofetil hydrochloride"],"synonyms":["Mycophenolate mofetil hcl","Mycophenolate mofetil hydrochloride","RS-61443-190"],"crossReferences":{"DailyMed":["mycophenolate%20mofetil%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1998. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201131","canonicalSmiles":"CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2","inchiKey":"FIPWRIJSWJWJAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERONYL BUTOXIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-8401","Piperonyl butoxide","Piperonyl butoxide technical"],"crossReferences":{"PubChem":["144204585","144214047","170464741","17389754"],"Wikipedia":["Piperonyl_butoxide"],"drugbank":["DB09350"],"chEBI":["32687"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL1201329","canonicalSmiles":"O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1","inchiKey":"CHQOEHPMXSHGCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHAPHAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Trimetaphan","Trimethaphan","Trimethaphan cation","Trimethaphan ion"],"crossReferences":{"drugbank":["DB01116"],"chEBI":["9728"]},"childChemblIds":["CHEMBL1245"],"linkedTargets":{"rows":["ENSG00000080644","ENSG00000117971"],"count":2},"linkedDiseases":{"rows":["EFO_0002614","EFO_1001461","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for hypertension and has 1 investigational indication."}
{"id":"CHEMBL1201390","canonicalSmiles":"C[C@]12C[C@H](O)[C@@]3(F)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO","inchiKey":"UUOUOERPONYGOS-CLCRDYEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOCINOLONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluocinolone"],"crossReferences":{"drugbank":["DB12553"],"chEBI":["5108"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1201566","drugType":"Protein","blackBoxWarning":true,"name":"DARBEPOETIN ALFA","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aranesp","Aranesp sureclick"],"synonyms":["Darbepoetin","Darbepoetin alfa","Darbepoetin alfa,recombinant","KRN-321","KRN321","NESP","Nespo"],"crossReferences":{"DailyMed":["darbepoetin%20alfa"],"DrugCentral":["5157"]},"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0003086","EFO_0001642","HP_0001919","EFO_0000403","MONDO_0007254","MONDO_0003002","EFO_0000311","EFO_1001951","EFO_0000565","MONDO_0002280","EFO_0000095","EFO_0003884","MONDO_0005299","EFO_0000702","EFO_0000574","EFO_0004272","EFO_0008583","EFO_0000612","MONDO_0043510"],"count":20},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL120708","canonicalSmiles":"CCCCn1c(=O)n(Cc2ccccc2F)c(=O)c2[nH]c(Cc3ccc(NC(C)=O)cc3)nc21","inchiKey":"JHSHXKJSPVHPCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL120708","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275974"],"drugbank":["DB02008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229677","canonicalSmiles":"CC(C)CCC(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"PQUULPKGCNPPBX-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229677","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06868"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231545","canonicalSmiles":"Cc1cccc2c1C(=O)N(c1cc(-c3ccccc3)ccc1O)C2=O","inchiKey":"ROMNEYAQUBNRLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231545","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233057","canonicalSmiles":"COP(=O)(N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC","inchiKey":"LJBUJRWZZYUNKX-JAJWTYFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233057","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03392"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233867","canonicalSmiles":"O=c1cc(-c2ccccc2)c2ccc(O)c(O)c2o1","inchiKey":"JRVIIPJSVKTPBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DNDI1417012","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNDI1417012"],"crossReferences":{"drugbank":["DB08049"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236104","canonicalSmiles":"O=C(O)CCC(=O)Nc1ccc(Br)cn1","inchiKey":"XFYYQDHEDOXWGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236104","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["845483"],"drugbank":["DB08578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1289110","canonicalSmiles":"CN1c2ccccc2C(NCCCCCCC(=O)O)c2ccc(Cl)cc2S1(=O)=O","inchiKey":"JICJBGPOMZQUBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIANEPTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-39823277","Jnj-39823277","S-1574","Stablon","TPI-1062","Tianeptine"],"crossReferences":{"Wikipedia":["Tianeptine"],"drugbank":["DB09289"]},"childChemblIds":["CHEMBL2361572"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1318287","canonicalSmiles":"C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1.O=C([O-])[C@H](O)[C@@H](O)C(=O)O.O=C([O-])[C@H](O)[C@@H](O)C(=O)O","inchiKey":"HSMKTIKKPMTUQH-WBPXWQEISA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOLINIUM TARTRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1271","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ansolysen"],"synonyms":["NSC-759890","Pentolinium tartrate","Pentolonium tartrate","Pentolonum bitartrate"],"crossReferences":{"PubChem":["50106735","90341731"],"chEBI":["55326"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1322884","canonicalSmiles":"CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C","inchiKey":"SBNFWQZLDJGRLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOTHRIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Full marks"],"synonyms":["D-phenotrhin","Hegor antipoux","NSC-758668","Phenothrin","S-2539F","Sumithrin"],"crossReferences":{"PubChem":["144204849","144211887","170465585","26747802"],"Wikipedia":["Phenothrin"],"drugbank":["DB13717"],"chEBI":["34916"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for parasitic infection."}
{"id":"CHEMBL1365675","canonicalSmiles":"Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1","inchiKey":"QXAITBQSYVNQDR-ZIOPAAQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITRAZ","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amitraz","Certifect","NSC-324552","U-36,059","U-36-059","U-36059"],"crossReferences":{"PubChem":["144204851","144208555","144211247","170465703","26747826","26753711"],"Wikipedia":["Amitraz"],"drugbank":["DB11373"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1402684","canonicalSmiles":"CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)Nc3ccccc32)cc1","inchiKey":"PHPUXYRXPHEJDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENISATIN ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Australia"," Germany"," France"," United Kingdom"," United States"],"classes":["Hepatotoxicity"],"year":1971},"tradeNames":["Isocrin","Lavema","Veripaque"],"synonyms":["Acetphenolisatin","NSC-117186","NSC-59687","Oxyphenisatin acetate","Oxyphenisatin diacetate","Oxyphenisatine acetate"],"crossReferences":{"PubChem":["144205204","144205205","170466798","26754500","29215359"],"drugbank":["DB14627"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Australia,  Germany,  France,  United Kingdom and  United States initially in 1971 due to Hepatotoxicity."}
{"id":"CHEMBL144673","canonicalSmiles":"CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1","inchiKey":"DTOUUUZOYKYHEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXETIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oraldene","Sterisil"],"synonyms":["Hexetidine","Hexopyrimidine","NSC-17764"],"crossReferences":{"PubChem":["144203975","170465729","26748327","93576718"],"drugbank":["DB08958"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL1614652","canonicalSmiles":"O=C1c2ccccc2S(=O)(=O)N1CCCCNC[C@H]1CCc2ccccc2O1","inchiKey":"YGYBFMRFXNDIPO-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPINOTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Repinotan"],"crossReferences":{"Wikipedia":["Repinotan"],"drugbank":["DB06506"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1672635","canonicalSmiles":"Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl","inchiKey":"XMBUPPIEVAFYHO-KPZWWZAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAD-140","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RAD-140","RAD140","Rad-140","Rad140","Testolone","Vosilasarm"],"crossReferences":{"drugbank":["DB13939"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1689063","canonicalSmiles":"NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O","inchiKey":"NDCUAPJVLWFHHB-UHNVWZDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVIBACTAM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nxl-104"],"synonyms":["Avibactam","NXL104","Nxl-104 free acid"],"crossReferences":{"DailyMed":["avibactam%20sodium"],"drugbank":["DB09060"],"chEBI":["85984"]},"childChemblIds":["CHEMBL2107817"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL1697771","canonicalSmiles":"O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1","inchiKey":"ALLWOAVDORUJLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBAMIPIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mucosta","NSC-758955","OPC-12759","Proamipide","Rebamipide","Rebator"],"crossReferences":{"PubChem":["144205013","170465891","174006202","26749027"],"Wikipedia":["Rebamipide"],"drugbank":["DB11656"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1697826","canonicalSmiles":"CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2","inchiKey":"DVLBYTMYSMAKHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAPERAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AHR-3000","BAYER 1362","BAYER-1362","Butaperazine","Butyrylperazine","RIKER 595","RIKER-595"],"crossReferences":{"drugbank":["DB13213"]},"childChemblIds":["CHEMBL2106507"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697849","canonicalSmiles":"Clc1ccc(C/C(=C\\CN2CCCC2)c2ccccc2)cc1","inchiKey":"WDYYVNNRTDZKAZ-XDHOZWIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRROBUTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrrobutamine"],"childChemblIds":["CHEMBL3989488"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743071","drugType":"Antibody","blackBoxWarning":false,"name":"SIRUKUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNTO 136","CNTO-136","Sirukumab"],"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_1001209","EFO_0000685","EFO_0008518","EFO_0005761","MONDO_0100096","EFO_0002690","MONDO_0002009","MONDO_0004979","EFO_0000540"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1743086","drugType":"Antibody","blackBoxWarning":false,"name":"VATELIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBR 500","GBR-500","SAR-339658","SAR339658","Vatelizumab"],"linkedTargets":{"rows":["ENSG00000164171"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003929"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL188185","canonicalSmiles":"CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1","inchiKey":"RHLJLALHBZGAFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUNAZOSIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bunazosin","Bunazosin hydrochloride"],"crossReferences":{"Wikipedia":["Bunazosin"],"drugbank":["DB12230"]},"childChemblIds":["CHEMBL3182014"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1902931","canonicalSmiles":"CSC(=O)c1c(C(F)F)nc(C(F)(F)F)c(C(=O)SC)c1CC(C)C","inchiKey":"YUBJPYNSGLJZPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITHIOPYR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211467","26757326"],"drugbank":["DB15230"],"chEBI":["81987"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908370","canonicalSmiles":"N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"FYMHQCNFKNMJAV-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINAFLOXACIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xtoro"],"synonyms":["AL-60371","Finafloxacin"],"crossReferences":{"drugbank":["DB09047"],"chEBI":["85176"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 4 investigational indications."}
{"id":"CHEMBL1933349","canonicalSmiles":"COc1ccc2cc(-c3cc(-c4cc(Cl)cc(Cl)c4)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1","inchiKey":"DNTVJEMGHBIUMW-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0893","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0893","Mk-0893","Mk0893"],"crossReferences":{"drugbank":["DB12044"]},"childChemblIds":["CHEMBL2159354"],"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL207994","canonicalSmiles":"COc1cc(OC)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl","inchiKey":"URQYPXQXSVUVRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207994","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2095208","canonicalSmiles":"CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1","inchiKey":"ZCIGNRJZKPOIKD-CQXVEOKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COBICISTAT","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tybost"],"synonyms":["Cobicistat","Cobicistat on silicon dioxide","GS-9350"],"crossReferences":{"DailyMed":["cobicistat"],"drugbank":["DB09065"],"chEBI":["72291"]},"linkedTargets":{"rows":["ENSG00000160870","ENSG00000106258","ENSG00000160868","ENSG00000021461"],"count":4},"linkedDiseases":{"rows":["EFO_0000765","EFO_0007448","MONDO_0100096","EFO_0000544","EFO_0001068","EFO_0002614","EFO_0000220","EFO_0000764","EFO_0000180","MONDO_0020743","EFO_0003060","EFO_0000311"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL2104318","canonicalSmiles":"O=S(=O)([O-])CCSSCCS(=O)(=O)[O-].[Na+].[Na+]","inchiKey":"KQYGMURBTJPBPQ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMESNA","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2009034","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimesna","NSC-716976","NSC-760345"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104668","canonicalSmiles":"CCC(CC)(CNC(=O)CCCO)c1cccc(OC)c1","inchiKey":"LMBMDLOSPKIWAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMBUTRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Embutane","T-61"],"synonyms":["Embutramid","Embutramide","HOE 18 680","HOE-18-680","HOE-18680"],"crossReferences":{"PubChem":["170465662"],"drugbank":["DB01487"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105665","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O","inchiKey":"FLFGNMFWNBOBGE-FNNZEKJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELACYTARABINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP 4055","CP-4055","Elacytarabine","P-4055"],"crossReferences":{"drugbank":["DB05494"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107783","canonicalSmiles":"O=C(O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)c1","inchiKey":"MFFBXYNKZHTCEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAPRENEPAG","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taprenepag"],"crossReferences":{"drugbank":["DB12623"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108232","drugType":"Unknown","blackBoxWarning":false,"name":"COAL TAR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphosyl","Aquatar","Capasal","Clinitar","Cocois co","Denorex","Fototar","Gelcotar","Genisol","Ionil t","Ionil-t","Ionil-t-plus","Neutrogena","Patterson's","Pentrax","Polytar af","Polytar plus","Pomade u.b.h.","Psoriderm","St johns","Stantar","Vanseb-t","Zetar"],"synonyms":["Coal tar","Coal tar (in shampoo)","Coal tar (non shampoo)","Coal tar solution","Coal tar, prepared","Coal tar,colloidal","Coal tar,crude","Coal tar,refined","Estar","Lavatar","Pix lithanthracis","Pixalbol"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
{"id":"CHEMBL2109465","drugType":"Antibody","blackBoxWarning":false,"name":"QAX-576","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dectrekumab","QAX-576","Qax-576","Qax576"],"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","EFO_0005854","EFO_0000768","EFO_0004212","MONDO_0004979","EFO_0000717","EFO_0000384","EFO_0009448"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2109495","drugType":"Antibody","blackBoxWarning":false,"name":"E2.3","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E2.3"],"linkedTargets":{"rows":["ENSG00000072274","ENSG00000106327"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","EFO_0002428","EFO_0001378"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109570","drugType":"Antibody","blackBoxWarning":false,"name":"SONEPCIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asonep","Isonep","LT-1009","LT1009","Sonepcizumab","Sphingomab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110561","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM LEXIDRONAM PENTASODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["samarium%20sm-153%20lexidronam%20pentasodium"]},"childChemblIds":["CHEMBL2096660"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL2111100","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC","inchiKey":"JMUHBNWAORSSBD-WKYWBUFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIFAMURTIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["L-MTP-PE","Mifamurtide"],"childChemblIds":["CHEMBL2107354"],"linkedTargets":{"rows":["ENSG00000167207"],"count":1},"linkedDiseases":{"rows":["EFO_0000637"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL22097","canonicalSmiles":"CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21","inchiKey":"FJIKWRGCXUCUIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORMETAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorotemazepam","Loramet","Lormetazepam","Methyllorazepam","WY-4082"],"crossReferences":{"Wikipedia":["Lormetazepam"],"drugbank":["DB13872"],"chEBI":["52993"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2220482","canonicalSmiles":"C[C@@H](N)[C@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O)[C@@H]1O","inchiKey":"KJBRSTPUILEBDR-YBNFDXCTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2220482","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15080"]},"childChemblIds":["CHEMBL2206195"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28319","canonicalSmiles":"Nc1ccccc1O","inchiKey":"CDAWCLOXVUBKRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUESTIOMYCIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["o-aminophenol","ortho-aminophenol"],"crossReferences":{"PubChem":["144208130","17388842","85148769"],"Wikipedia":["2-Aminophenol"],"drugbank":["DB01726"],"chEBI":["18112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297053","canonicalSmiles":"CN(Cc1cc2ccccc2n1C)C(=O)/C=C/c1ccc(N)nc1","inchiKey":"AKFPMLBVLWZSQX-CSKARUKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL297053","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039509","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2CCCCC2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CN1CCCCC1","inchiKey":"HNDXPZPJZGTJLJ-UEJFNEDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILDIPIROSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zuprevo"],"synonyms":["Tildipirosin"],"crossReferences":{"drugbank":["DB11470"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL312448","canonicalSmiles":"Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1","inchiKey":"HUCJFAOMUPXHDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XYLOMETAZOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Balminil","Xylometazoline"],"crossReferences":{"PubChem":["11111974","11111975","174007471","50100368","50104259","90340774"],"Wikipedia":["Xylometazoline"],"drugbank":["DB06694"],"chEBI":["10082"]},"childChemblIds":["CHEMBL1256400"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for nasal congestion and eye allergy and has 1 investigational indication."}
{"id":"CHEMBL3187229","canonicalSmiles":"C#C[C@]1(OC(=O)CCCCCC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"APTGJECXMIKIET-WOSSHHRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187229","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206578"],"drugbank":["DB14678"],"chEBI":["34894"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL319497","canonicalSmiles":"NCCCC[C@@H](N)C(=O)O","inchiKey":"KDXKERNSBIXSRK-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL319497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29216420"],"drugbank":["DB03252"],"chEBI":["16855"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL324455","canonicalSmiles":"CC(=O)Nc1c(O)cc(C(=O)O)cc1[N+](=O)[O-]","inchiKey":"JIDRTCHFBHJIDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL324455","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08570"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3251296","canonicalSmiles":"Cc1cn2c(nc1=O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12","inchiKey":"WLLOAUCNUMYOQI-JAGXHNFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TK-112690","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["O2,2'-anhydro-5-methyluridine","TK-112690","Tk-112690"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301615","canonicalSmiles":"Cl.c1ccc2cc([C@]34CNC[C@H]3C4)ccc2c1","inchiKey":"ACVMJAJGCQUPKX-LIOBNPLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENTANAFADINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301621","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Centanafadine hydrochloride","DOV 216,419","DOV 216,419 HYDROCHLORIDE","DOV-216419 HYDROCHLORIDE","EB-1020","EB-1020 HYDROCHLORIDE"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301674","canonicalSmiles":"CCCCCNC(=O)c1coc([C@@H]2[C@H]3CC[C@H](O3)[C@@H]2Cc2ccccc2CCC(=O)[O-])n1.[Na+]","inchiKey":"WOHSQDNIXPEQAE-QBKVZTCDSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IFETROBAN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301673","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-180291-02","Ifetroban sodium"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3317857","canonicalSmiles":"O=C(O)C[C@@H]1CC[C@H](NC(=O)Cc2cccs2)B(O)O1","inchiKey":"IOOWNWLVCOUUEX-WPRPVWTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VABORBACTAM","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["RPX-7009","RPX7009","Vaborbactam"],"crossReferences":{"DailyMed":["vaborbactam"],"drugbank":["DB12107"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for urinary tract infection and has 2 investigational indications."}
{"id":"CHEMBL3358841","canonicalSmiles":"CC(C)[C@]12O[C@H]1[C@@H]1O[C@]13[C@]1(O[C@H]1C[C@@]1(O)C4=C(CC[C@]31C)C(=O)OC4)[C@@H]2O","inchiKey":"OKRSVUYYCJPECG-LFGMFVMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3358841","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL352764","canonicalSmiles":"CC(C)SCC[C@@H](N)[C@H](O)C(=O)NNC(=O)c1cccc(Cl)c1","inchiKey":"BYBVYIPUGPZRSX-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-357300","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-357300"],"crossReferences":{"drugbank":["DB07377"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544978","canonicalSmiles":"C[C@@H]1O[C@H](C)CN2c3c(cc4c(N5C(=O)OC[C@@H]5C)noc4c3F)CC3(C(=O)NC(=O)NC3=O)[C@@H]12","inchiKey":"ZSWMIFNWDQEXDT-ZESJGQACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLIFLODACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-0914","AZD0914","ETX-0914","ETX0914","Zoliflodacin"],"crossReferences":{"drugbank":["DB12817"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545051","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-37440","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alk-fak inhibitor cep-37440","Cep-37440"],"linkedTargets":{"rows":["ENSG00000171094","ENSG00000169398"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545108","canonicalSmiles":"O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CCCNCCCO)ccc1Cl","inchiKey":"HSQAARMBHJCUOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD9056","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD9056","Azd 9056","Azd-9056","Azd9056"],"crossReferences":{"drugbank":["DB12594"]},"childChemblIds":["CHEMBL3415305"],"linkedTargets":{"rows":["ENSG00000089041"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL368347","canonicalSmiles":"COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O","inchiKey":"PUETUDUXMCLALY-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-SECOISOLARICIRESINOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-secoisolariciresinol","Secoisolariciresinol"],"crossReferences":{"Wikipedia":["Secoisolariciresinol"],"drugbank":["DB12179"],"chEBI":["65004"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3686884","canonicalSmiles":"CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCOC)cc21","inchiKey":"IBHOLSBDZMIPPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7090","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7090","E7090","Tasurgratinib"],"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0001421","EFO_0005221"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707215","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O","inchiKey":"UFKLOBYBVCBTBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETANAUTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diphenhydramine monoacefyllinate","Etanautine"],"crossReferences":{"DrugCentral":["4534"],"drugbank":["DB13636"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707239","canonicalSmiles":"Cn1c(=O)c2c(ncn2CCOC(=O)c2cccnc2)n(C)c1=O","inchiKey":"ZWIAODBBEZGVPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFYLLINE NICOTINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etofylline nicotinate"],"crossReferences":{"drugbank":["DB13842"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707287","canonicalSmiles":"O=C([O-])c1cccnc1.O=C([O-])c1cccnc1.O=C([O-])c1cccnc1.[Al+3]","inchiKey":"NSFYKDVWNTWJOK-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINIUM NICOTINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aluminium nicotinate"],"crossReferences":{"DrugCentral":["4764"],"drugbank":["DB13576"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707326","drugType":"Antibody","blackBoxWarning":false,"name":"BUROSUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crysvita"],"synonyms":["Burosumab","Burosumab-twza","KRN-23","KRN23"],"crossReferences":{"DailyMed":["burosumab-twza"]},"linkedTargets":{"rows":["ENSG00000118972"],"count":1},"linkedDiseases":{"rows":["Orphanet_437","HP_0002148","EFO_1002027","Orphanet_89936","Orphanet_35125","EFO_0004260"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL3707359","drugType":"Unknown","blackBoxWarning":false,"name":"DAXIBOTULINUMTOXINA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daxibotulinumtoxina","RTI-150","RTI150","RTT150"],"linkedTargets":{"rows":["ENSG00000132639"],"count":1},"linkedDiseases":{"rows":["HP_0000473"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707390","canonicalSmiles":"CN1C(=O)N(C)C2C1N(C)C(=O)N2C","inchiKey":"XIUUSFJTJXFNGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBICAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adaptol","Glycoluril, 1,3,4,6-tetramethyl-","Mebikar","Temgicoluril","Tetramethylglycoluril"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL380955","canonicalSmiles":"CN(C)C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1","inchiKey":"WFFMEXQHWXEKBV-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380955","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08246"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833363","drugType":"Small molecule","blackBoxWarning":false,"name":"CERIUM OXALATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3990854","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cerium oxalate"],"crossReferences":{"DrugCentral":["4403"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL391910","canonicalSmiles":"C[C@H](CCc1ccc(O)cc1)NC(=O)Cc1c(-c2ccccc2)[nH]c2ccccc12","inchiKey":"APLJSSOXDWUNGV-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3939295","canonicalSmiles":"C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1","inchiKey":"MBWRLLRCTIYXDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"H3B-6527","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["H3B-6527","H3b 6527","H3b-6527"],"crossReferences":{"drugbank":["DB15169"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL395091","canonicalSmiles":"CN[C@]1(c2ccccc2Cl)CCCCC1=O","inchiKey":"YQEZLKZALYSWHR-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESKETAMINE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-ketamine","Esketamine","Jnj-54135419","Keta-s","Ketamine, (s)-","Ketamine, s-","Ketaved","L-ketamine","S-(-)-ketamine","S-ketamine"],"crossReferences":{"DailyMed":["esketamine%20hydrochloride"],"PubChem":["144206757"],"drugbank":["DB11823"],"chEBI":["60799"]},"childChemblIds":["CHEMBL2364609"],"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000183454","ENSG00000116032","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003086","HP_0000360","MONDO_0041052","MONDO_0002009","EFO_0007453","EFO_0009516","EFO_0003843","EFO_0000311","EFO_0000546","EFO_0003890","MONDO_0002050","MONDO_0001208","EFO_0001421","EFO_0003761"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL398435","canonicalSmiles":"CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1","inchiKey":"OEKWJQXRCDYSHL-FNOIDJSQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TICAGRELOR","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brilinta","Brilique"],"synonyms":["AR-C126532XX","AZD-6140","AZD6140","Possia","Ticagrelor"],"crossReferences":{"DailyMed":["ticagrelor"],"Wikipedia":["Ticagrelor"],"drugbank":["DB08816"],"chEBI":["68558"]},"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003086","Orphanet_232","EFO_0000275","EFO_0000266","EFO_0003913","EFO_0003914","EFO_0008585","EFO_0003870","EFO_0000712","EFO_0003884","HP_0004419","EFO_0000400","EFO_0008586","EFO_0000685","HP_0001685","EFO_0001645","EFO_0000556","EFO_0000319","GO_0070527","EFO_0002615","EFO_0003106","MONDO_0100096","MONDO_0000831","EFO_0008583","EFO_0007328","EFO_0000612","EFO_0000341","HP_0031273","MONDO_0005148","EFO_0005672","EFO_0004265"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 8 approved and 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989825","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"LUNRMKZYOGNOTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOGUANIL PAMOATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL747","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CI-501","CN-14,329-23A","CN-14329-23A","Chloroguanide triazine pamoate","Cycloguanil embonate","Cycloguanil pamoate","NSC-77830","PAM-MR-807-23A"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for malaria."}
{"id":"CHEMBL3990001","drugType":"Antibody","blackBoxWarning":false,"name":"COSFROVIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zmapp"],"synonyms":["Cosfroviximab","c13C6-FR1"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990020","drugType":"Gene","blackBoxWarning":false,"name":"VADACABTAGENE LERALEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JCAR-015","JCAR015","Vadacabtagene leraleucel"],"description":"Gene drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990276","canonicalSmiles":"O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O","inchiKey":"XBPUDTAATCFDRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALC","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["talc"]},"childChemblIds":["CHEMBL3989756"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for pleural effusion and has 4 investigational indications."}
{"id":"CHEMBL4093031","canonicalSmiles":"CNC(=O)c1c(-c2ccc(F)cc2)oc2ccc(-c3cc(C(=O)NC4(c5ncccn5)CC4)ccc3C)c(F)c12","inchiKey":"LZAUGCMVNLZVJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-929075","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-929075"],"crossReferences":{"drugbank":["DB14950"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL410414","canonicalSmiles":"CN(Cc1ccccc1)C(=O)[C@@H](NC(=O)c1cc2cc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)ccc2n1C)c1ccccc1","inchiKey":"TUOSYWCFRFNJBS-BHVANESWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIRLOTAPIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-742,033","CP-742033","Dirlotapide","Slentrol"],"crossReferences":{"Wikipedia":["Dirlotapide"],"drugbank":["DB11399"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4209157","canonicalSmiles":"O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4cc(C(F)(F)F)ccc4[nH]3)ccnc2N1","inchiKey":"NGFFVZQXSRKHBM-FKBYEOEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFIRAFENIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-283","Beigene-283","Bgb 283","Bgb-283","Lifirafenib"],"crossReferences":{"drugbank":["DB14773"]},"childChemblIds":["CHEMBL4298146"],"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL425386","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2[N+](=O)[O-])o1","inchiKey":"XUFDYUSOQQYQRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425386","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07408"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297489","canonicalSmiles":"Cc1nn(C)cc1CN1CCC(c2ccc(C(=O)Nc3ccccc3N)cc2)CC1","inchiKey":"JHDZMASHNBKTPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CXD-101","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd-9468","CXD-101","CXD101","Cxd-101","Cxd101","Hdac inhibitor cxd101","Hdac-in-4"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297566","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CASIMERSEN","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amondys 45"],"synonyms":["Casimersen","EXON-45: NG-12-0064","SRP-4045"],"linkedTargets":{"rows":["ENSG00000198947"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","Orphanet_98473"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for duchenne muscular dystrophy and muscular dystrophy."}
{"id":"CHEMBL4297609","canonicalSmiles":"Cc1cc(-c2ccccc2)c(C(=O)C(=O)Nc2ccc(N3CCN(c4ncc(F)cn4)CC3)cc2)n1C","inchiKey":"SUFPWYYDCOKDLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOROFIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F-901318","F901318","Olorofim"],"crossReferences":{"drugbank":["DB15245"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297643","canonicalSmiles":"Cc1cccc(/C=N/Nc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1","inchiKey":"HSKAZIJJKRAJAV-KOEQRZSOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APILIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apilimod","STA 5326","STA-5326","Sta-5326"],"crossReferences":{"drugbank":["DB05611"]},"linkedTargets":{"rows":["ENSG00000115020"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","Orphanet_1572","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297672","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLCOBALAMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mecobalamin","Methyl b12","Methylcobalamin"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297694","drugType":"Protein","blackBoxWarning":false,"name":"ANFIBATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agkisacucetin","Anfibatide"],"linkedTargets":{"rows":["ENSG00000185245"],"count":1},"linkedDiseases":{"rows":["EFO_0000612","MONDO_0019740"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297840","drugType":"Antibody","blackBoxWarning":false,"name":"TISLELIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-A317","BGN-1","BGN1","Bgb-a317","JHL-2108","JHL2108","Tislelizumab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["MONDO_0009348","EFO_1000172","MONDO_0003060","EFO_0003891","EFO_0000756","MONDO_0044887","EFO_1000657","MONDO_0007254","EFO_0004252","MONDO_0021063","EFO_0005952","EFO_0000708","MONDO_0001187","EFO_1001951","EFO_0000565","MONDO_0001056","EFO_1001480","MONDO_0002974","MONDO_0008903","EFO_0000182","EFO_0008528","EFO_0000183","MONDO_0002083","EFO_0000616","EFO_0002618","EFO_0006859","EFO_0005922","MONDO_0008170","EFO_1000350","EFO_0000403","MONDO_0007576","EFO_0000313","MONDO_0004986","EFO_0003060","EFO_0005221","MONDO_0008315","EFO_0000311","EFO_1001961","MONDO_0002691","EFO_0005537","EFO_0000702","EFO_0000574","MONDO_0003219","EFO_0006544"],"count":44},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 28 investigational indications."}
{"id":"CHEMBL456237","canonicalSmiles":"Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1","inchiKey":"KYWWJENKIMRJBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LXR-623","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lx-623","Lx623","Lxr-623","WAY-252623","Way252623"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594473","drugType":"Unknown","blackBoxWarning":false,"name":"ESCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aescin","Escin"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594552","drugType":"Antibody","blackBoxWarning":false,"name":"CUDAROLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cudarolimab","IBI-101","IBI101","Ibi101"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594561","drugType":"Enzyme","blackBoxWarning":false,"name":"INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INVAC-1","Invac-1","Invac-1, a double stranded dna plasmid vaccine construct encoding ubiquitin-human telomerase reverse transcriptase (htert) fusion protein"],"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460831","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CS)C(=O)O)C(=O)O","inchiKey":"RITKHVBHSGLULN-WHFBIAKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Gamma-Glutamyl-Cysteine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gamma-Glutamyl-Cysteine"],"crossReferences":{"Wikipedia":["Gamma-Glutamylcysteine"],"drugbank":["DB03408"],"chEBI":["17515"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46486","canonicalSmiles":"C[N+](C)(C)C","inchiKey":"QEMXHQIAXOOASZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAMETHYLAMMONIUM ION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetramethyl-Ammonium"],"crossReferences":{"drugbank":["DB03095"],"chEBI":["46020"]},"childChemblIds":["CHEMBL2288325","CHEMBL1209651","CHEMBL3187523"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650344","canonicalSmiles":"O=C(O)c1nc2ccccc2n(C2C[C@@H]3CCC[C@@H](C2)N3C2C[C@H]3CCC[C@H](C2)C3)c1=O","inchiKey":"COTYYZPYDJKKIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUNOBINOP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sunobinop","V-117957","V117957"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650685","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPIVOTIDE TETRAXETAN GALLIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650357"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL470365","canonicalSmiles":"Cc1ccccc1[C@H]1CCCN1C(=O)c1ccc(O)cc1O","inchiKey":"TWODFUZHWYZBHZ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL470365","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08442"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL476189","canonicalSmiles":"CC(C)=CCNc1ncnc2[nH]cnc12","inchiKey":"HYVABZIGRDEKCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N6-(2-Isopentenyl)Adenine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N6-(2-Isopentenyl)Adenine"],"crossReferences":{"PubChem":["4253531","554384"],"drugbank":["DB08768"],"chEBI":["17660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478464","canonicalSmiles":"Nc1cccc(Sc2ccc(/C=C/C(=O)N3CCOCC3)c(C(F)(F)F)c2C(F)(F)F)c1","inchiKey":"KLSZVPNVFKKIRD-FNORWQNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478464","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802140","canonicalSmiles":"CCc1cc(OC)ccc1-c1ccc(C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@](C)(Cc2ccccc2F)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc2ccc(-c3ccccc3C)nc2)C(N)=O)cc1","inchiKey":"ZLVRQSAYTXYDPX-VGLKCPPXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BMS-686117","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 686117","Bms-686117"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL491960","canonicalSmiles":"O=c1[nH]c(=S)[nH]c(-c2ccccc2)c1Cc1c(O)ccc2ccccc12","inchiKey":"RVNSQVIUFZVNAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMBINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cambinol"],"crossReferences":{"PubChem":["410126","4253568","90341827"],"drugbank":["DB15493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495072","canonicalSmiles":"Clc1ccc(CCC2(Cn3ccnc3)OCCO2)cc1","inchiKey":"NPIOYRIZNLPLDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495072","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06914"]},"childChemblIds":["CHEMBL541899"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL600","canonicalSmiles":"CC(=O)N[C@@H](CS)C(=O)O","inchiKey":"PWKSKIMOESPYIA-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLCYSTEINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A-cys","Acc-600","Acetadote","Acetylcysteine","Airbron","Cetylev","En-cys","Fabrol","Fluimucil","Fluimucil 600","Fluimucil long","Fluimucil n","Ilube","Mucomyst","Mucosil","Mucosil-10","Mucosil-20","N-Acetyl-L-Cysteine","Oronac 600","Parvolex","Respi-nac","Siran","Solmucol","Yournac"],"synonyms":["5052","Acetyl cysteine","Acetylcysteine","Broncholysin","Fluimicil","Fluimucetin","Mercapturic acid","N-acetyi-l-cysteine","N-acetyl-l-cysteine","NSC-111180","Oristar nalc","RK-0202","Respaire","Rk-0202","Syntemucol","Tixair"],"crossReferences":{"DailyMed":["acetylcysteine"],"PubChem":["144204428","144208276","170464792","26751489","50104028","56423146","855714","90340802"],"Wikipedia":["Acetylcysteine"],"drugbank":["DB06151"],"chEBI":["28939"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 5 approved and 97 investigational indications."}
{"id":"CHEMBL642","canonicalSmiles":"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1","inchiKey":"GOEMGAFJFRBGGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEBUTOLOL","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acebutolol","C07AB04","Sectral"],"crossReferences":{"DailyMed":["acebutolol%20hydrochloride"],"Wikipedia":["Acebutolol"],"drugbank":["DB01193"],"chEBI":["2379"]},"childChemblIds":["CHEMBL1200813"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","HP_0004308","EFO_0000319","EFO_1000635","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL70352","canonicalSmiles":"CCN(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"IVQOFBKHQCTVQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENACTYZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benactyzine"],"crossReferences":{"PubChem":["144205218","170466568","29215374"],"Wikipedia":["Benactyzine"],"drugbank":["DB09023"]},"childChemblIds":["CHEMBL1584883"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL73151","canonicalSmiles":"CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1","inchiKey":"JOAHPSVPXZTVEP-YXJHDRRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERGURIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Teluron","Terguride"],"crossReferences":{"PubChem":["11533045","144204835"],"drugbank":["DB13399"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL911","canonicalSmiles":"Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1","inchiKey":"ZAFYATHCZYHLPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZOLPIDEM","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ambien","Sanval","Zolpidem","Zolpidem civ"],"crossReferences":{"DailyMed":["zolpidem%20tartrate"],"PubChem":["144205024","170465242","26749064"],"Wikipedia":["Zolpidem"],"drugbank":["DB00425"],"chEBI":["10125"]},"childChemblIds":["CHEMBL3989820","CHEMBL1723343"],"linkedTargets":{"rows":["ENSG00000113327","ENSG00000163288"],"count":2},"linkedDiseases":{"rows":["MONDO_0000477","EFO_0003888","MONDO_0005090","HP_0000726","EFO_0008568","EFO_0001073","EFO_0004698","EFO_0020916","EFO_0007191","GO_0007568","EFO_0001072","EFO_0003890","MONDO_0002050","MONDO_0005180","EFO_0000673","EFO_0005230","EFO_0003877","EFO_0003918"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for insomnia and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL928","canonicalSmiles":"O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)[N-]1.[Na+]","inchiKey":"KSRLIXGNPXAZHD-HAZZGOGXSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"DANTROLENE SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201288","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dantrium","Dantrolene sodium","Revonto","Ryanodex"],"synonyms":["Dantamacrin","Dantrolen","Dantrolene sodium","Dantrolene sodium heptahydrate","Dantrolene sodium hydrate","Dantrolene sodium salt hemiheptahydrate","F-440","NSC-758403"],"crossReferences":{"DailyMed":["dantrolene%20sodium"],"PubChem":["50106202"]},"linkedTargets":{"rows":["ENSG00000198838","ENSG00000196218"],"count":2},"linkedDiseases":{"rows":["EFO_1001340","HP_0001257","MONDO_0005301","EFO_0020003","HP_0001945","EFO_0000712","EFO_1001919","EFO_1000632","Orphanet_3463"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 6 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
